Research & Development: Page 92
-
PharmaVoice Team/PharmaVoice
Table of Contents
VIEW on E-Solutions October 2006 Letter from the Managing Editor The Forum E-Solutions: Adoption is a Marathon not a Sprint — Pharmaceutical and biotech companies recognize the numerous benefits e-solutions can bring to their operations, but implementation is easier said than done. Company Listin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integrated eClinical Solutions: Be Afraid, Be Very Afraid…
Integrated eClinical Solutions: Be Afraid, Be Very Afraid… Timothy Pratt, Ph.D. Chief Marketing Officer and Principal Scientific Advisor Why are lots of EDC vendors talking about how integrated their systems are? And what’s this new buzzword emerging — eClinical? Is this just EDC? Why sho...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Metrics: It's All About Performance
By Taren Grom, Editor From the clinic to the market, the ability to drive process improvement and operational excellence for sponsors and providers through strategic metrics has never been more important. Metrics encourage effectiveness, efficiencies, and appropriate levels of control. No matter ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
A refreshing focus Pending patent expirations, the FDA, compliance issues, product liability and related lawsuits, stock price pressures, fully integrated and targeted promotion, return on promotional investment, accountability, fair balance, mergers and consolidations, salesforce effectiveness, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Calculated Risks -- Bassil Dahiyat
In a business climate in which caution and proven outcomes dominate, Bassil Dahiyat, Ph.D., is a daring and enthusiastic exception to the rule. Risk is not a word that frightens the young entrepreneur. He founded his own company, Xencor Inc., directly after completing his Ph.D., based on the prot...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
GSW Launches Pink Tank Specialty marketing group offers expertise in understanding and speaking to women. Remarkably, many marketers don’t realize that women connect with brands differently from men. We established Pink Tank to help companies understand those differences and to counsel them on ho...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Events October 2006 Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pink Ribbons of Opportunity
By Cynthia Borda Despite advances in breast cancer treatments, this is still an area of unmet need. Significant opportunities exist in this market, especially for products that are targeted and that have fewer side effects. Tremendous progress has been made in treating breast cancer. Survival rat...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
resource hub Grand Opening of the Pennsylvania Biotechnology Center The Pennsylvania Biotechnology Center of Bucks County located in Doylestown, Pa., is a $15 million, 62,000-square-foot facility, funded in part by a grant from the Commonwealth of Pennsylvania. The center seeks to advance biotech...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Technology Use Among Regulatory Affairs Professionals Rising Many regulatory affairs professionals rely on both paper and electronic submissions, and 70% of these professionals expect this trend to continue into the future, according to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Bio Meets Pharma to Form the New Age of Biopharma
By Denise Myshko In the future, broad-based companies will choose the most appropriate approach, whether small molecule or biologic, to create new interventions. The distinction between biotech and pharma is blurring. The result: broad-based companies use their expertise in a disease and the unde...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
A.J. Kazimi says public perception is one obstacle midsize companies face. Jill Balderson says patients need more information about diseases. Dr. Dahiyat’s technology could change the face of medicine. October 2006 PharmaVOICE On the Cover Midsize pharma: Moving and shaking the industry Unlike th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
October is National Breast Cancer Awareness Month. We at PharmaVOICE thought it appropriate, therefore, to focus this month’s therapeutic specialty on this important area of research and treatment. According to the American Cancer Society, breast cancer death rates are going down. The chance of d...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies InfoMedics’ Treatment Educator Improves Patient Understanding and Increases Brand Loyalty InfoMedics Inc. has released Treatment Educator, a tool for improving prescription compliance through patient education and treatment unders...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Scientific Advantage Launches MSL Outsourcing Subsidiary The new division addresses client requests for MSL professionals. Scientific Advantage LLC has formed MSL Advantage LLC to fill MSL staffing positions within pharmaceutical, biotech, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Discovery Bug -- Dr. Graham Allaway
By Kim Ribbink Graham Allaway, Ph.D. Whether Dr. Allaway is exploring the open seas in his single-handed Laser or investigating uncharted areas in virology, he attends to both with equal passion, commitment, and focus. In small companies, people are pulling in the same direction; it’s truly a tea...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
IRBs The Safety Gatekeepers
By Denise Myshko Current pressures to speed drugs to market have resulted in the increased use of independent, centralized institutional review boards as an alternative to academic IRBs, because they can offer faster and more efficient protocol reviews. Institutional review boards, or IRBs, are a...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharma Has The Data But Not The Information
Michael Rosenberg, M.D., MPH, President and CEO of Health Decisions Inc., Chapel Hill, N.C., discusses why, compared with other large industries, pharma’s automation processes lag behind. Are you involved with clinical research? If so, take a moment to imagine what if every clinical research assi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Nanotech Sector Continues Strong Growth Sales, Marketing, and R&D Trends from Industry Analysts The commercialization of nanotechnology continues to gain momentum worldwide, according to The Nanotech Report, 4th Edition, a comprehensive and up-to-date reference study on nanotechnology, releas...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DIA 2006 -- Annual Conference
DIA 2006 — Breaks Attendance Records September 2006 Sanjay Gupta, M.D., senior medical correspondent for the health and medical unit at CNN, practicing neurosurgeon, and an assistant professor of neurosurgery gave the keynote speech at the 42nd Annual DIA Meeting. The conference drew record numbe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Perspective
Staffing Multinational Trials A Time for Creative Solutions In the past decade, an unprecedented push to field Global clinical trials has boosted the demand for patients and CRAs from Asia to Zambia. Sponsors expect rock-bottom pricing, transparency, local staff with a breadth of experience, and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Consumers Talk Back Countering DTC Criticism Challenging many of the assumptions of both academic and public-policy critics of DTC, CommonHealth filed a research report with the FDA based on analysis of 440 transcripts of actual provider-patient interactions in community-practice settings recorde...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
A Team Approach Breaking Down the Silos Debugging the Pipeline with Graham Allaway, Ph.D. Name that Brand Clinical Gatekeepers: Institutional Review Boards The Forum for the Industry Executive September 2006 Volume 6 Number 8 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ben Franklin and Taren Grom at the MediciGroup booth at the 42nd Annual Drug Information Association meeting in Philadelphia. An innovative approach Many consider Ben Franklin to be one of America’s most prolific inventors. Throughout his colorful life, Ben Franklin pursued scientific knowledge w...
By PharmaVoice Team • Jan. 2, 2008
Previous
